The purpose of this research study is to collect blood from patients with B-cell lymphoma who are scheduled to receive lymphodepletion chemotherapy and CAR-T cells. Research on blood samples can help in understanding how the body and cancer respond to these treatments.

Do you have a diagnosis of schizophrenia? Are you interested in improving your mental functioning? Did you participate in one of the phase III clinical trial programs for BI 425809 (trial # 1346-0011, 1346-0012, 1346-0013). If so, you may be eligible to participate in an extension study. Compensation provided.

Are you pregnant or did you recently have a baby? Do you have Medicaid insurance? If so, you may be able to participate in a research study to help find ways for more pregnant people to get the dental care they need. Compensation provided.

Metabolism is the process your body uses to make energy. The main purpose of this study is to observe the impact of metabolic processes on cognition and behavior.

Do you or someone you know have military experience? Do you want to help investigate techniques which may save our injured military service members? You may be able to participate in a study focused on expanding the understanding of fresh whole blood transfusion in emergency military trauma. We are seeking healthy volunteers willing to donate the equivalent of one unit of whole blood in order to investigate this topic in the resource limited setting of field military trauma. Donors will be asked for a few hours of their time and compensation will be provided.

Fuel for Thought: How do sugar and fat affect each other in the brain? Do you ever wonder what happens in your brain when you eat dessert? And why sugary and fatty foods are so appealing? If so, you may eligible to participate in a research study to understand the impact of sugar and fat on the brain!

Have you been recently diagnosed with Mycobacterium Avium Complex (MAC) lung disease and are looking into options for treatment? You may be able to take part in a trial of a new, oral medication called SPR720. We are doing this study to learn more about both the safety of the medication and how well it works to combat MAC lung disease. Compensation will be provided to all participants who complete the trial.

This study is assessing the effectiveness and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when given with atezolizumab and bevacizumab as a first-line treatment for unresectable, locally advanced or metastatic patients with hepatocellular carcinoma (HCC). TIGIT is thought to play an important role in HCC's response to immunotherapy treatments such as atezolizumab. This study will assess whether the addition of tiragolumab to atezolizumab and bevacizumab will improve response and clinical outcomes.

Since Crisfield's founding on the Chesapeake Bay, the environment has been an important part of community life, economy and culture. In an effort to deal with current environmental challenges such as nuisance flooding, storms, and erosion, the U.S. Environmental Protection Agency is partnering with the City of Crisfield and Maryland Sea Grant to explore nature-based solutions to flooding such as green infrastructure and marsh restoration. Join a team of Crisfield area residents in the Crisfield Resilience Academy to work with scientists and co-develop community solutions to issues associated with local flooding. For additional information, please join the upcoming informational webinar or contact Jenna Hartley at hartley.jenna@epa.gov. Crisfield Resilience Academy participants will receive a stipend of up to $400/six months for participating.

If you have high risk prostate cancer, you may be able to participate in a research study to find out decreasing or increasing your radiation and hormonal therapy has an effect on your cancer.